Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt

Researching ownership and past performance data can provide insights into stock opportunities. For Gyre Therapeutics, Inc. (NASDAQ: GYRE), public companies hold the majority stake, affecting stock movement. Institutional investors and insiders also play a role, influencing company decisions and growth potential.